Score Overview
See the full market ranking โ
Rxsight Inc fundamental performance
Between 2021 and 2025, revenue grew from $ 22M to $ 134M and net income went from -$ 48M to -$ 38M. Revenue increased in 60% of the years measured; net income in 40%.
Rxsight Inc currently holds a 5-year HDB Score of 4.8 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 7.06 | โ |
1 Year2025-08-12 | $ 7.35 | -3.95% |
5 Years2021-08-12 | $ 12.54 | -43.70% |
All Time2021-07-30 | $ 16.00 | -55.88% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2021-07-30 |
|---|---|---|---|---|
| Price | $ 7.06 | $ 7.35 | $ 12.54 | $ 16.00 |
| Return | โ | -3.95% | -43.70% | -55.88% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 127M | -$ 46M | $ 208M |
| 2025 | $ 134M | -$ 38M | $ 228M |
| 2024 | $ 139M | -$ 27M | $ 237M |
| 2023 | $ 89M | -$ 48M | $ 127M |
| 2022 | $ 49M | -$ 66M | $ 105M |
| IPO2021 | $ 22M | -$ 48M | $ 159M |
Explore beyond RXST
You're looking at Rxsight Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score โ 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.